Peptide receptor radionuclide therapy with177lu-dotatate in a case of concurrent neuroendocrine tumors and meningioma: Achieving two things in a single action [Eşzamanlı nöroendokrin tümör ve menenjiyom olgusunda177lu-dotatate ile peptid reseptör radyonüklid tedavisi: Tek bir uygulama ile iki hastalığın tedavisi]

Assadi, M and Rekabpour, S.J and Amini, A and Dadgar, H and Nemati, R and Gholamrezanezhad, A and Nabipour, I and Jafari, E and Ahmadzadehfar, H (2021) Peptide receptor radionuclide therapy with177lu-dotatate in a case of concurrent neuroendocrine tumors and meningioma: Achieving two things in a single action [Eşzamanlı nöroendokrin tümör ve menenjiyom olgusunda177lu-dotatate ile peptid reseptör radyonüklid tedavisi: Tek bir uygulama ile iki hastalığın tedavisi]. Molecular Imaging and Radionuclide Therapy, 30 (2). pp. 107-109. ISSN 2146-1414

Full text not available from this repository.
Official URL: https://mirt.tsnmjournals.org/archives/archive-det...

Abstract

We present a partial response of peptide receptor radionuclide therapy (PRRT) with177Lu-DOTATATE in a case of concurrent neuroendocrine tumors (NETs) and meningioma. In addition to the valuable role of PRRT in inoperable NETs, it has been demonstrated that this treatment can be a promising therapy for progressive meningioma, especially in patients with low grade and refractory to standard regime.

Item Type: Article
Uncontrolled Keywords: F-FDG-PET/CT; 68Ga-DOTATATE PET/MRI; Neuroendocrine tumor; PRRT
Subjects: R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Divisions: Faculty of Medicin > Department of Radiology
Depositing User: خدیجه شبانکاره
Date Deposited: 27 Dec 2021 08:31
Last Modified: 27 Dec 2021 08:31
URI: http://eprints.bpums.ac.ir/id/eprint/9503

Actions (login required)

View Item View Item